(Q37602303)

21 August 2017

1 reference

title

The epidermal growth factor system of ligands and receptors in cancer (English)

1 reference

21 August 2017

William J Gullick

1

1 reference

21 August 2017

publication date

1 September 2009

1 reference

European Journal of Cancer

21 August 2017

published in

1 reference

21 August 2017

volume

45 Suppl 1

1 reference

21 August 2017

page(s)

205-210

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

21 August 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

1 reference

7 January 2021

The protein tyrosine kinase family of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

EGF and its receptor: historical perspective. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Return of the chalones

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Binding specificities and affinities of egf domains for ErbB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

The neuregulin family of genes and their multiple splice variants in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Characterization of the cell membrane-associated products of the Neuregulin 4 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Mapping nucleolar and spliceosome localization sequences of neuregulin1-beta3.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Heregulins implicated in cellular functions other than receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Endocytosis and intracellular trafficking of ErbBs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Structure-based view of epidermal growth factor receptor regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Ligand-induced ErbB receptor dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Receptor tyrosine kinases: mechanisms of activation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

The role of protease activity in ErbB biology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Role of ErbB4 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Kinome signaling through regulated protein-protein interactions in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Simulating complex intracellular processes using object-oriented computational modelling.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

EGF-ERBB signalling: towards the systems level

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Human squamous cell lung cancers express increased epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Update on epidermal growth factor receptor mutations in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Lung cancer: intragenic ERBB2 kinase mutations in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

ErbB receptors: new insights on mechanisms and biology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Regulating the dynamics of EGF receptor signaling in space and time

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

A Recurrent Chromosome Breakpoint in Breast Cancer at theNRG1/Neuregulin 1/HeregulinGene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Design of growth factor antagonists with antiangiogenic and antitumor properties

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970035-8

7 January 2021

10.1016/S0959-8049(09)70035-8

Identifiers

DOI

1 reference

21 August 2017

1 reference